March 29, 2020

Diagnostic Testing For STD’s Market: Global Industry Size, Share, Growth, Trends, Analysis and Forecast 2018 to 2026

The latest market report published by Credence Research, Inc. “Global Diagnostic Testing for STD’s Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global diagnostic testing for the STD market is expected to reach US$ 19,716.9 million in 2017 and is expected to reach US$ 42,329.1 million by 2026, increasing to CAGR by 8.9 per cent from 2018 to 2026.

Market Insights

According to statistics provided by the World Health Organization (WHO), there are approximately 357 million new cases of 1 in 4 sexually transmitted infections of gonorrhea, syphilis, chlamydia and trichomoniasis every year. More than 30 different types of pathogens are reported to be sexually transmitted, of which only bacterial infections are curable. Viral infections are incurable with symptomatic relief only through effective treatment protocols. Rising incidence of resistance to antibiotics results in a high demand for early detection of sexually transmitted diseases.

Browse Full Report Originally Published by Credence Research at

At present chlamydia and syphilis together are leading the type segment for diagnostic testing for STD’s market. The key factors responsible for their dominance are higher indulgence of unsafe sex with multiple partners throughout the globe and increasing sexual contact with anal and oral regions. HIV infection testing is witnessing impressive growth due to availability of highly sensitive and effective molecular diagnostic kits for PCR and ELISA techniques. Increasing campaigning by governmental and non-governmental agencies resulting in early screening for HIV infection.

In the current scenario laboratory testing are reigning the location segment for diagnostic testing for STD’s market. The key parameters responsible for its excellent growth are availability of skilled workforce and establishment of new diagnostic laboratories due to financial pumping from government healthcare agencies. Point of care testing will register huge growth during the forecast period owing to availability of latest molecular diagnostic kits with improved ergonomic designs, portability, and quick turnaround time related to diagnosis.

According to Center for Disease Control and Prevention (CDC) in 2017, approximately 2.3 million people are suffering with sexually transmitted disease in the United States. Factors responsible for the dominance of North America are existence of well-developed healthcare infrastructure and domicile of key players. In Europe the market growth is determined by the supportive regulatory environment provided by European Medical Agency favoring the growth of STD’s diagnostic kits. There has been rampant increase in the spread of STD’s throughout the European Union region on account of the recent refugee influx from the Levant region. Asia Pacific is set to register impressive growth during the forecast period on account of rising prevalence of sexually transmitted disease and proactive government initiative in establishing diagnostic centers to curb the spread and fatality of STD’s.

Archrivals competing in the diagnostic testing for STD’s market are Abbott Laboratories, Inc., Bio-Rad Laboratories, Inc., bioMerieux, Danaher Corporation, Diasorin S.p.A, F.Hoffman La-Roche Ltd., Hologic, Inc., MedMira, Inc., Qiagen, Inc., and Siemens Healthcare AG.

Key Market Movements:

  • The rising incidence rate of sexually transmitted disease throughout the globe
  • Technological adevanmcent in the molecular diagnostic testing kits used for screening of sexually transmitted diseases
  • Supportive regulatory scenario favoring market growth and increasing public health awareness resulting in early screening

Access Free Sample Copy of Research Report:

 [Note: Our Free Complimentary Sample Report Accommodate a Brief Introduction To The Synopsis, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology are also Included]

Report Scope by Segments

By Type

 • Syphilis Testing

 • Gonorrhea Testing

 • Chlamydia Testing

 • Herpes Simplex Virus Testing

 • Human Immunodeficiency Virus Testing

 • Human Papilloma Virus Testing

 • Others

 By Location Type

 • Laboratory Testing

 • Point of Care Testing

By Geography Segment

  • North America (the U.S., Rest of North America)
  • Europe (U.K., Germany, France, Rest of Europe)
  • Asia Pacific (China, Japan, India, Rest of Asia Pacific)
  • Rest of World (Middle East & Africa (MEA), Latin America)

Key questions answered in this report

  • How is the market assessment determined by applying inorganic and organic market growth strategies?
  • What will be the CAGR and for the report diagnostic testing for STD’s market?
  • How is the competitive landscape mapped and what significant it is in understanding the competition prevalent in the market?
  • What is the disease etiology for sexually transmitted diseases?
  • Which is the leading and fastest growing type segment in diagnostic testing for STD’s market?
  • Which is the leading and fastest growing location segment in diagnostic testing for STD’s market?
  • Which is the leading and fastest growing regional segment in diagnostic testing for STD’s market?

Access Free Sample Copy of Research Report:

Leave a Reply

Your email address will not be published. Required fields are marked *